Opthalamic Drug Delivery Systems
Ophthalmic drug delivery systems encompass a range of specialized methods and technologies designed for the targeted administration of medications to the eyes. These systems play a crucial role in treating various ocular conditions by enhancing drug efficacy, improving patient compliance, and minimizing side effects.
Intraocular Injections:
Intravitreal Injections: Direct injections into the vitreous cavity of the eye, commonly used for treating conditions such as macular degeneration or diabetic retinopathy. Implantable Devices:
- Ocular Inserts: Solid devices placed in the conjunctival sac that release drugs gradually over an extended period, providing a sustained therapeutic effect.
- Drug-Eluting Contact Lenses: Contact lenses designed with materials that release drugs onto the ocular surface for controlled and prolonged drug delivery.
Challenges and Innovations:
- Tear Turnover: Addressing the dynamic nature of tear turnover is a challenge for ensuring prolonged drug retention in the eye.
- Corneal Barrier: Overcoming the corneal barrier is a focus for developing strategies that facilitate effective drug penetration into intraocular tissues.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico